PIM
NVO

Penobscot Investment Management’s Novo Nordisk NVO Stock Holding History

Penobscot Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$922K Sell
19,240
-300
-2% -$12.9K 0.06% 175
2026
Q1 		$718K Sell
19,540
-4,465
-19% -$212K 0.06% 190
2025
Q4 		$1.22M Sell
24,005
-425
-2% -$21.7K 0.09% 159
2025
Q3 		$1.36M Sell
24,430
-2,433
-9% -$142K 0.1% 151
2025
Q2 		$1.85M Sell
26,863
-6,459
-19% -$439K 0.16% 123
2025
Q1 		$2.31M Sell
33,322
-2,247
-6% -$186K 0.22% 95
2024
Q4 		$3.06M Sell
35,569
-5,850
-14% -$633K 0.28% 75
2024
Q3 		$4.93M Buy
41,419
+620
+2% +$82.7K 0.44% 56
2024
Q2 		$5.82M Buy
40,799
+2,040
+5% +$270K 0.56% 45
2024
Q1 		$4.98M Buy
38,759
+6,585
+20% +$784K 0.53% 47
2023
Q4 		$3.33M Buy
32,174
+4,269
+15% +$422K 0.39% 61
2023
Q3 		$2.54M Buy
27,905
+3,945
+16% +$348K 0.34% 67
2023
Q2 		$1.94M Buy
23,960
+580
+2% +$47.4K 0.32% 76
2023
Q1 		$1.86M Hold
23,380
– – 0.32% 75
2022
Q4 		$1.58M Hold
23,380
– – 0.28% 88
2022
Q3 		$1.17M Hold
23,380
– – 0.22% 100
2022
Q2 		$1.3M Hold
23,380
– – 0.23% 101
2022
Q1 		$1.3M Sell
23,380
-1,100
-4% -$56.5K 0.19% 110
2021
Q4 		$1.37M Hold
24,480
– – 0.19% 110
2021
Q3 		$1.18M Sell
24,480
-2,000
-8% -$96.7K 0.17% 122
2021
Q2 		$1.11M Hold
26,480
– – 0.16% 123
2021
Q1 		$893K Hold
26,480
– – 0.14% 125
2020
Q4 		$925K Hold
26,480
– – 0.16% 119
2020
Q3 		$919K Hold
26,480
– – 0.17% 107
2020
Q2 		$867K Sell
26,480
-24
-0.1% -$766 0.18% 108
2020
Q1 		$798K Sell
26,504
-6,100
-19% -$182K 0.19% 108
2019
Q4 		$944K Sell
32,604
-400
-1% -$11.1K 0.18% 113
2019
Q3 		$853K Sell
33,004
-9,290
-22% -$235K 0.17% 113
2019
Q2 		$1.08M Sell
42,294
-4,356
-9% -$108K 0.22% 100
2019
Q1 		$1.22M Hold
46,650
– – 0.26% 93
2018
Q4 		$1.07M Sell
46,650
-7,240
-13% -$161K 0.26% 89
2018
Q3 		$1.27M Sell
53,890
-940
-2% -$22.9K 0.27% 89
2018
Q2 		$1.26M Sell
54,830
-9,010
-14% -$214K 0.29% 88
2018
Q1 		$1.57M Sell
63,840
-460
-0.7% -$12.1K 0.38% 74
2017
Q4 		$1.73M Hold
64,300
– – 0.48% 65
2017
Q3 		$1.55M Sell
64,300
-140
-0.2% -$3.16K 0.46% 67
2017
Q2 		$1.38M Buy
64,440
+440
+0.7% +$8.88K 0.44% 69
2017
Q1 		$1.1M Buy
64,000
+1,180
+2% +$20.5K 0.37% 75
2016
Q4 		$1.13M Buy
62,820
+780
+1% +$14.1K 0.39% 75
2016
Q3 		$1.29M Sell
62,040
-4,600
-7% -$114K 0.45% 71
2016
Q2 		$1.79M Buy
66,640
+4,800
+8% +$132K 0.64% 55
2016
Q1 		$1.68M Sell
61,840
-15,880
-20% -$425K 0.63% 52
2015
Q4 		$2.26M Buy
77,720
+2,000
+3% +$55.4K 0.71% 47
2015
Q3 		$2.05M Buy
75,720
+1,450
+2% +$41.1K 0.69% 48
2015
Q2 		$2.03M Buy
74,270
+320
+0.4% +$9K 0.63% 53
2015
Q1 		$1.97M Buy
73,950
+3,400
+5% +$78.3K 0.63% 55
2014
Q4 		$1.49M Buy
70,550
+1,160
+2% +$25.9K 0.47% 65
2014
Q3 		$1.65M Buy
69,390
+800
+1% +$18.4K 0.55% 63
2014
Q2 		$1.58M Buy
68,590
+950
+1% +$21K 0.53% 63
2014
Q1 		$1.54M Buy
67,640
+240
+0.4% +$5.11K 0.55% 62
2013
Q4 		$1.25M Buy
67,400
+1,300
+2% +$22.7K 0.44% 67
2013
Q3 		$1.12M Buy
66,100
+3,800
+6% +$63.9K 0.44% 66
2013
Q2 		$965K Buy
+62,300
New +$1.04M 0.4% 68

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Penobscot Investment Management's NVO Position: Q2 2026 in Review

Penobscot Investment Management reduced its Novo Nordisk (NVO) stake by 1.5% in Q2 2026, selling an estimated $12.9K and leaving 19,240 shares worth $922K. The position accounts for 0.06% of the portfolio, ranked #175.

Penobscot Investment Management first reported a position in NVO in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.82M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Penobscot Investment Management held 19,240 shares of Novo Nordisk worth $922K as of Q2 2026.
  • Penobscot Investment Management sold 300 Novo Nordisk shares in Q2 2026, an estimated $12.9K.
  • Novo Nordisk made up 0.06% of Penobscot Investment Management's portfolio in Q2 2026, its #175 holding.
  • Penobscot Investment Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Novo Nordisk position peaked at $5.82M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.